High PER1 expression in lung adenocarcinoma patients is associated with STK11-mutation, low hypoxia scores, low tumor and immune cell admixture, high tumor purity, and low tumor-associated PD-L1 expression. This evidence concerns the gene CD274 and neoplasm.